Avalon GloboCare (ALBT) Short Interest Ratio & Short Volume

Short interest is the volume of Avalon GloboCare shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 83,400 shares of ALBT short. 1.74% of Avalon GloboCare's shares are currently sold short. Learn More on Avalon GloboCare's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.74% of Avalon GloboCare's floating shares are currently sold short.

Avalon GloboCare saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 83,400 shares, a drop of 29.7% from the previous total of 118,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Avalon GloboCare currently has issued a total of 11,100,000 shares. Some of Avalon GloboCare's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Avalon GloboCare currently has a public float of 4,780,000 shares.

1.74% of Avalon GloboCare's shares are currently sold short. Here is how the short interest of companies compare to Avalon GloboCare: TRACON Pharmaceuticals, Inc. (32.74%), Gamida Cell Ltd. (7.11%), Windtree Therapeutics, Inc. (0.54%), Finch Therapeutics Group, Inc. (1.70%), Palisade Bio, Inc. (0.21%), Fresh Tracks Therapeutics, Inc. (0.17%), TC Biopharm (Holdings) Plc (30.07%), Scinai Immunotherapeutics Ltd. (0.29%), Titan Pharmaceuticals, Inc. (0.59%), Creative Medical Technology Holdings, Inc. (2.17%),

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

Short selling ALBT is an investing strategy that aims to generate trading profit from Avalon GloboCare as its price is falling. ALBT shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Avalon GloboCare occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALBT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALBT, twice per month. The most recent reporting period available is March, 31 2024.